News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Infrared Systems International Subsidiary AquaLiv, Inc. Discusses Recent Events in Kenya Concerning its HIV/AIDS Treatment



8/30/2011 11:28:10 AM

SILVERDALE, Wash., Aug. 30, 2011 /PRNewswire/ -- Representatives from Infrared Systems International (OTCBB: IFRS) subsidiary, AquaLiv, Inc., have returned from Kenya with updates concerning their NatuRx(TM) HIV/AIDS treatment.

The company previously announced AquaLiv representatives would be visiting Kenya to make preparations for an upcoming clinical trial of NatuRx(TM) HIV/AIDS. According to the company, while attempting to register the treatment as a drug, Kenyan officials instead recommended filing as an alternative medicine.

"Unlike traditional drugs, all NatuRx(TM) treatments are information-based and do not rely on chemical interaction with active molecules to function," stated AquaLiv CEO, Craig Hoffman. "The Kenyan authorities recognized that our unique treatment has a negligible toxicity and cannot be misused. It is impossible to overdose. In our first regulatory organization experience with NatuRx(TM), the treatment was acknowledged and understood far easier than we anticipated."

Mr. Hoffman continued, "Even more exciting than this warm welcome is the outcome of an approved registration as an alternative medicine. If approved, we will be able to market and sell NatuRx(TM) HIV/AIDS without further clinical trials. And, approval could be granted in the next 30-60 days. The biggest hurdle in biotech is regulatory approval for sale and ongoing costs of continued clinical trials. This will be a big a win for AquaLiv."

In order to produce valuable data, the company intends to continue with the planned clinical trial even though it may not be needed to sell the treatment in Kenya. Several clinics and physicians were identified to participate in the trial. Required protocol is being discussed and budgets are being established for the various participants.

"Kenya is known as the 'Gateway to Africa' because other African nations usually follow suit," added Bill Wright, CEO of Infrared Systems International. "Achieving success in Kenya is generally a successful forecast for all of Africa."

Based on AquaLiv's patented BioT Bioinformation Technology, NatuRx formulations utilize novel wave-based information composites in lieu of molecules for treatment. The solutions have no contraindications, are non-toxic and resembles common mineral water in analysis.

For more information about AquaLiv, visit their website: http://www.aqualiv.net

About Infrared Systems International:

Infrared Systems International, through its subsidiaries, offers unique solutions and applications for a variety of industries and emerging technologies.

AquaLiv, Inc. is a life sciences research and development company creating novel products for numerous industries. The company's patented technology alters the behavior of organisms, including plants and humans, without chemical interaction. From increased crop yields to drug-free medicine, AquaLiv is providing innovative, ingredient-free solutions to the world's largest problems. To learn more about AquaLiv, please visit: www.aqualiv.net.

Focus Systems, Inc. is a service orientated, desktop virtualization, and VoIP information technology provider. Focus Systems' service essentially eliminates the need for their customers to buy, deploy, and maintain IT infrastructure. The move to cloud computing lowers customers' total cost of ownership by shifting critical systems to Focus -- including servers, backup, software, operating systems, updates, power, cooling, facility space, and internal staffing requirements. For more information, please visit: www.focus-sys.com.

Safe Harbor: Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.

Contact:
Infrared Systems International
360-536-4220

SOURCE Infrared Systems International


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES